TrialJournal of addiction medicine

A Long-acting Naltrexone Implant (iSTEP-N) for Opioid Use Disorder: First-in-Human Phase I Trial.

Steven M Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.